Clinical Trial Update: Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of sonidegib and buparlisib in advanced or metastatic basal cell carcinoma was terminated, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Nevus Syndrome

Drugs mentioned

• Buparlisib (buparlisib)
• Odomzo (sonidegib)

Snippet

Sponsor: Anne Chang | Conditions: Carcinoma, Basal Cell, Recurrent Skin Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-01-29